Diabetes mellitus is becoming increasingly prevalent and is considered a rapidly growing
concern for healthcare systems. Besides the cardiovascular complications, diabetes mellitus …

OBJECTIVE The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective,
controlled trial of 1,791 patients with type 2 diabetes to determine whether intensive …

Background There is a lack of data on the relationship between glycemic control and
cardiovascular end points in hemodialysis patients with diabetes mellitus. Methods and …

Introduction Changes in albuminuria or estimated glomerular filtration rate (eGFR) can be
used as a surrogate endpoint of end-stage kidney disease (ESKD) in people with type 2 …

Objective: Kidneys in a Box (KIB) was developed to identify the effect of a performance
improvement CME (PI-CME) project on the management of patients with diabetes who are at …

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in
hypertensive type 2 diabetic patients. Background In hypertensive type 2 diabetic patients …

Background: Chronic kidney disease (CKD) is a global health challenge that contribute to
substantial patients' morbidity and mortality. Hypertension is highly prevalent among CKD …

Background The role of glycemic control and its variability on the rate of kidney function
decline after the onset of diabetic kidney disease (DKD) remains unclear. Methods The …

Aims To examine the relationship between average glucose (AG) and HbA 1c in patients
with and without chronic kidney disease (CKD) and type 2 diabetes. Materials and methods …

OBJECTIVE To examine the association of hemoglobin (Hb) A1c variability with
microvascular complications in the large cohort of subjects with type 2 diabetes from the …